Your browser doesn't support javascript.
loading
A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.
Toledano, Shira; Lu, Huayi; Palacio, Agustina; Ziv, Keren; Kessler, Ofra; Schaal, Shlomit; Neufeld, Gera; Barak, Yoreh.
Afiliación
  • Toledano S; Cancer Research and Vascular Biology Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
  • Lu H; Second Hospital of Jilin University, Changchun, Jilin Province, P.R. China.
  • Palacio A; Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, United States of America.
  • Ziv K; Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, United States of America.
  • Kessler O; Cancer Research and Vascular Biology Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
  • Schaal S; Cancer Research and Vascular Biology Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
  • Neufeld G; Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, United States of America.
  • Barak Y; Department of Ophthalmology and Visual Sciences, University of Massachusetts School of Medicine, Massachusetts, United States of America.
PLoS One ; 11(12): e0168122, 2016.
Article en En | MEDLINE | ID: mdl-28036336

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neovascularización Coroidal / Semaforinas / Furina Límite: Animals / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neovascularización Coroidal / Semaforinas / Furina Límite: Animals / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Israel
...